Rapid drug abuse test DOA004
alcoholfor barbituratesfor benzodiazepines

rapid drug abuse test
rapid drug abuse test
Add to favorites
Compare this product
 

Characteristics

Applications
for abused drugs
Tested parameter
for methadone, MET, for phencyclidine, AMP, alcohol, for cocaïne, for marijuana, for opiates, for benzodiazepines, for buprenorphine, for propoxyphene, for barbiturates, for ketamine, for oxycodone
Sample type
saliva
Other characteristics
self-test
Result display time

10 min

Description

Instructions for use for testing of any combination of the following drugs: Amphetamine (AMP), Cocaine (COC), Marijuana (THC), Methamphetamine (MET), Opiates (OPI), Benzodiazepines (BZO), Barbiturates (BAR) , Buprenorphine (BUP) , Ketamine (KET) , Methadone (MTD) , Methylenedioxymethamphetamine (MDMA) , Oxycodone (OXY) , Phencyclidine (PCP) , Propoxyphene (PPX) , K2, Alcohol(ALC) INTENDED USE The Saliva Drug Rapid Test (Colloidal Gold Method) is a lateral flow chromatographic immunoassay for the qualitative detection of Amphetamine, Cocaine, Marijuana, Methamphetamine, Opiates, Benzodiazepines, Barbiturates , Buprenorphine, Ketamine, Methadone,Methylenedioxymethamphetamine,Oxycodone,Phencyclidine,Propoxyphen, K2, Alcohol and their metabolites in saliva at the following cut-off concentrations. The detection window when drugs can be detected in saliva specimens using this test is also indicated. This assay provides only a qualitative, preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) or Liquid Chromatography/mass spectrometry (LC/MS) are the preferred confirmatory methods. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used.

Catalogs

No catalogs are available for this product.

See all of Hangzhou Singclean Medical Products‘s catalogs

Exhibitions

Meet this supplier at the following exhibition(s):

ArabHealth 2025
ArabHealth 2025

27-30 Jan 2025 Dubai (United Arab Emirates) Stand R.A39

  • More information
    *Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.